This inventor holds 32 USPTO granted patents and 8 published patent applications and 8 EPO patents, primarily in Microbiome Protection. Top assignees: Synthetic Biologics, Inc., Theriva Biologics, Inc., Synthetic Biologies, Inc.. Active years: 1999-2026.
Location History:
- Gaithersburg, MD (US) (1999 - 2003)
- Ijamsville, MD (US) (2003)
- Rockville, MD (US) (2016 - 2024)
Company Filing History:
20 out of 39 
6 out of 13 
3 out of 4 
Years Active: 1999-2026
Areas of Expertise:
Title: Innovations by Sheila Connelly in Biologics and Antibiotic Resistance
Introduction
Sheila Connelly is a prominent inventor located in Rockville, MD, specializing in the field of biologics and antibiotic resistance. With a robust portfolio of 30 patents, she has significantly contributed to advancements in therapeutic formulations and methods that impact healthcare and drug efficacy.
Latest Patents
Among her latest innovations are two notable patents:
1. **Beta-lactamase formulations and uses thereof** - This invention offers formulations that include a beta-lactamase, particularly modified-release formulations that ensure substantial release within the intestines. These formulations have therapeutic uses that could revolutionize the treatment of certain infections.
2. **Method and compositions for inhibiting or preventing adverse effects of oral antibiotics** - In this patent, Connelly presents various compositions and methods designed to protect the gastrointestinal microbiome from disruptions caused by antibiotic treatments, promoting healthier gut flora.
Career Highlights
Sheila Connelly has built a commendable career within the biotech industry, working for companies such as Synthetic Biologics, Inc. and Theriva Biologics, Inc. Her work has focused on developing innovative solutions to address critical challenges in medicine, particularly in the realms of antibiotic resistance and therapeutic delivery systems.
Collaborations
Throughout her career, Connelly has collaborated with notable professionals in the field, including Michael Kaleko and Vincent Wacher. These collaborations have enabled the combination of diverse expertise, leading to the development of innovative solutions that advance the understanding and application of biotherapeutics.
Conclusion
Sheila Connelly's contributions to biotechnology and pharmacology are marked by her inventive spirit and commitment to improving healthcare outcomes. With her extensive patent portfolio exemplifying her work, she continues to be a vital force in the fight against antibiotic resistance and the advancement of therapeutic formulations.